Issue 49, 2015

Coumarins as privileged scaffold for anti-inflammatory drug development

Abstract

Several literature reports had highlighted the significance of coumarin nucleus as a source of potential candidates for anti-inflammatory drug development. Various natural coumarins such as umbelliferone, scopoletin, visnadin, marmin and esculetin demonstrated potent anti-inflammatory activity through various mechanisms. Keeping in view the importance of naturally occurring coumarins, researchers have extensively explored these by synthesizing various derivatives as anti-inflammatory agents. The present review describes different synthetic modifications carried out on coumarin nucleus, assessment of their anti-inflammatory potential and structure–activity relationship (SAR) study, reported during 1992–2014. SAR may help medicinal chemists in rational design of future anti-inflammatory molecules based on coumarin scaffold.

Graphical abstract: Coumarins as privileged scaffold for anti-inflammatory drug development

Article information

Article type
Review Article
Submitted
30 Mar 2015
Accepted
20 Apr 2015
First published
20 Apr 2015

RSC Adv., 2015,5, 38892-38905

Coumarins as privileged scaffold for anti-inflammatory drug development

J. Grover and S. M. Jachak, RSC Adv., 2015, 5, 38892 DOI: 10.1039/C5RA05643H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements